Research paper
Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: A novel testing of the hyperthermia effect

https://doi.org/10.1016/j.ejpb.2010.10.007Get rights and content

Abstract

The synthesis of three types of mesoporous materials is reported: pure mesoporous silica (MCM-41), a nanocomposite of mesoporous silica with hydroxyapatite (MCM-41-HA) and mesoporous silica/gold nanorods nanocomposite (MCM-41-GNRs). The mesoporous materials were characterized by X-ray diffraction, N2 adsorption isotherms, FTIR spectroscopy, transmission electron microscopy, and scanning electron microscopy. The samples were loaded with coumarin thiourea derivatives (I–IV) having functional groups of varying sizes and the in vitro release assays were monitored, and the release behavior was investigated as a function of soaking time in simulated body fluid. Two release stages were obtained in MCM-41, MCM-41-HA and MCM-41-GNRs loaded samples with the early release stages accounting for about 30% of loaded derivatives. These early release stages are characterized by Higuchi rate constant values nearly twice the values associated with the second release stages. The influence of substituent size on the release rate constants was explained in terms of sorption sites and hydrogen bonding with silanol groups on silicates. The release of coumarin derivatives loaded on MCM-41, MCM-41-HA and MCM-41-GNRs occurs over remarkably long time of the order of about 260 h with faster release rates in loaded MCM-41 and MCM-41-GNRs samples compared with MCM-41-HA ones. The role of hyperthermia effect in enhancing release rates was investigated by subjecting loaded MCM-41-GNRs to near infrared (NIR) radiation at 800 nm. This would be of significance in targeted drug release using hyperthermia effect. Unlike hydroxyl apatite, loading MCM-41 with gold nanorods does not affect the release kinetics. Only when these samples are irradiated with NIR photons, does the release occur with enhanced rates. This property could be valuable in selected targeting of drugs.

Graphical abstract

Mesoporous silica coating gold nanorods was synthesized. The role of hyperthermia effect in enhancing release rates was investigated by subjecting loaded MCM-41-GNRs to near infra red (NIR) radiation at 800 nm. This would be of significance in targeted drug release using hyperthermia effect. Unlike hydroxyl apatite, loading MCM-41 with gold nanorods does not affect the release kinetics. Only when these samples are irradiated with NIR photons, does the release occur with enhanced rates. This property could be valuable in selected targeting of drugs.

The early 5 h of coumarin I release from MCM-41-GNRs (○) and MCM-41-GNRs irradiated at 807 nm using a diode laser source (●). There is an increase in release by about 47.6%.

  1. Download : Download full-size image

Introduction

The administration of drugs by a drug delivery system provides advantages over conventional drug therapies because the drug is delivered locally rather than systemically. This minimizes harmful side effects [1]. The entire drug dose needed for a desired period is administered at one time and released in a controlled manner. Other potential advantages include drug targeting, improved compliance and comfort [2]. Numerous systems have been studied for controlled drug delivery, such as biodegradable polymers [3], hydroxyapatite (HA) [4], [5], [6], calcium phosphate cement [7], [8], [9], xerogels [10], [11], hydrogels [12], [13] mesoporous silica [14] and others.

Mesoporous materials show ordered arrangements of channels and cavities of different geometries built up from SiO2 units [15]. These materials exhibit variable pore size (2–50 nm), high surface areas (ca. 1000 m2/g), high pore volume (ca. 1 cm3/g) and homogeneous nanostructures which can be tailored by varying the synthesis procedure [16]. The pore walls have high surface density of silanol groups (Sisingle bondOH) that could be reactive toward appropriate guest molecules [17].

Siliceous mesoporous materials have the advantage of being biocompatible and degradable in aqueous solutions, and thus problems related to the removal of the material after use can be avoided.

Since 2001, when MCM-41 was purposed for the first time as controlled delivery system [18], much research efforts have been devoted to tailor the chemical properties of mesoporous carriers at the nanometer scale to achieve a better control over loading and release of molecules. The mesoporous carrier is selected according to the features of the guest molecule and the targeted application. Therefore, different guest molecules have been successfully confined into mesoporous silicas. Some of these molecules are drugs [18], [19], [20], [21], [22], [23], [24], [25]. Other guest molecules consisted of biologically active species, such as proteins, e.g. bovine serum albumin (BSA) [26] and certain amino acids [27]. The textural properties (i.e., pore diameter, surface area and pore volume) of mesoporous materials are key factors that govern molecules adsorption and release [28]. Moreover, functionalization of silica walls using different organic groups has been revealed as the main strategy to modulate molecule loading and release.

Nanoparticles derived from gold provide an attractive system for diagnostic and therapeutic applications owing to their ease of preparation, ready bioconjugation, good biocompatibility, and unique optical properties [29], [30], [31].

In particular, gold nanorods (GNRs) are important metal nanomaterial with distinctive shape-dependent optical properties. Especially, they possess two distinct plasmon bands, one associated with the transverse mode and the other with the longitudinal modes. These properties suggest several advantages of GNRs for the applications not only in biological sensing [32] and imaging [33] but more importantly, they are potential candidates for localized photothermal therapy because they mediate strong plasmon-induced surface heat flux upon absorption of near infrared light [34], [35], [36], [37].

Although most of the synthetic methods used for the preparation of metal nanorods suffered from limitations, either in the amount of material [38] or in the yield of nanorods, when compared to nanospheres [39], Nikoobakht and El-Sayed recently reported a variation of the so-called seed-mediated method [40] that affords the synthesis of relatively large amounts of nanorods with very little contamination by nanospheres and variable aspect ratio.

Coumarin derivatives possess a wide range of applications as anticoagulants [41], antitumor [42], photosensitizers [43], anti-HIV [44], antimicrobial [45] and anti inflammatory agents [46]. Coumarin derivatives have been liked to other molecules in gene expression studies [47] as well as in salmonella detection [48]. Coumarin derivatives are also currently used as fluorogenic dyes in proteomics [49].

In the present communication, we report the application of mesoporous silicate, mesoporous silicate coating gold nanorods and mesoporous silicates loaded by apatite nanostructures as carriers for coumarin thiourea derivatives (I–IV) linked to functional groups of varying sizes in an effort to correlate group size and release rate constants. The advantage of using mesoporous silicates as carriers of the present coumarin derivatives is the remarkably long time-scale of release (Scheme 1).

Loading mesoporous silicates with gold nanorods offers a novel method of enhanced release based on hyperthermia effect. Plasmon-resonant gold nanorods are highly effective at transducing NIR light into heat leading to localized hyperthermia. Hyperthermia is currently under consideration as a noninvasive approach to cancer therapy, in which biological tissues are exposed to higher than normal temperatures to promote the selective destruction of abnormal cells [37]. Our present approach offers a dual action in which hyperthermia effect can produce severe blebbing in cell membranes, and render them permeable to chemical agents. The other simultaneous effect is the enhanced release of drugs loaded on mesoporous silicates. The biosafety of metallic gold is well known, and they have been used in vivo since the 1950s and recently the noncytotoxicity of gold nanoparticles in human cells has been studied in detail by Wyatt et al. [50].

Section snippets

Materials

Analytical grade tetraethyloxysilane (TEOS) was purchased from Merck. Cetyltrimethyl ammonium bromide (CTAB), sodium hydroxide (NaOH), dipotassiumhydrogenphosphate (K2HPO4), sodium chloride (NaCl), potassium chloride (KCl), calcium chloride dihydrate (CaCl2·2H2O), sodium sulphate decahydrate (Na2SO4·10H2O), magnesium chloride hexahydrate (MgCl2·6H2O) and hydrochloric acid (HCl) were purchased from Fluka. Tetrachloroauric acid (HAuCl43H2O), cetyltrimethyl ammonium bromide (CTAB),

Characterization studies

Fig. 1a displays TEM observation of MCM-41 particles. MCM-41 silica material was obtained as small spherical particles with a diameter of about 1 μm. The TEM image (Fig. 1b) shows the characteristic hexagonal arrangement of uniform pores and unidirectional canals for the MCM-41 sample. SEM imaging shows the growth of crystalline particles, and the surface was completely covered with them (Fig. 2a). A similar image was reported by Sousa et al. [17]. The template-guided one-pot synthesis method

Conclusions

The applicability of mesoporous silica MCM-41 and MCM-41-HA materials as matrices for the controlled release was studied for coumarin thiourea derivatives in which the thiourea moiety is linked to functional groups of varying sizes. An effort is made to correlate group size and release rate constants and to establish the influence of the pore architecture and size on the coumarin thiourea derivatives release. The results indicated that mesoporous silica is a potential carrier for encapsulating

References (61)

  • M. Lin et al.

    Structure and release behavior of PMMA/silica composite drug delivery system

    J. Pharm. Sci.

    (2007)
  • R. Mellaerts et al.

    Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica

    Eur. J. Pharm. Biopharm.

    (2008)
  • L.S. Fonseca et al.

    Nanocapsule@xerogel microparticles containing sodium diclofenac: a new strategy to control the release of drugs

    Int. J. Pharm.

    (2008)
  • M. Vallet-Regi et al.

    Bone–regenerative bioceramic implants with drug and protein controlled delivery capability

    Prog. Solid State Chem.

    (2008)
  • F. Balas et al.

    l-Trp adsorption into silica mesoporous materials to promote bone formation

    Acta Biomater.

    (2008)
  • D.P. O’Neal et al.

    Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles

    Cancer Lett.

    (2004)
  • C. Spino et al.

    Anti-HIV coumarin from calophyllum seed oil

    Bioorg. Med. Chem. Lett.

    (1998)
  • F. Cottigli et al.

    Antimicrobial evaluation of coumarins and flavonoids from the stems of Daphne gnidium L

    Phytomedicine

    (2001)
  • M. Hu et al.
  • J.E. Barralet et al.

    Cements from nanocrystalline hydroxyapatite

    J. Mater. Sci. Mater. Med.

    (2004)
  • J.A. Jansen et al.

    Biological behavior of injectable calcium–phosphate (CaP) cement

    Mater. Sci. Forum.

    (2003)
  • R.P. Real et al.

    A new method to produce macropores in calcium–phosphate cements

    Biomaterials

    (2002)
  • M. Bohner

    Calcium orthophosphates in medicine: from ceramics to calcium–phosphate cements

    Injury

    (2000)
  • J. Karaycki

    Monolithic xero-and-aerogels for gel-glass processes

  • P. Caliceri et al.

    Controlled release of biomolecules from temperature-sensitive hydrogels prepared by radiation polymerization

    J. Controlled Release

    (2001)
  • T.G.F. Sousa Andreza Sousa et al.

    SBA15-collagen hybrid material for drug delivery applications

    J. Non-Cryst. Solid

    (2006)
  • J.Y. Ying et al.

    Synthesis and applications of supramolecular-templated mesoporous materials

    Angew Chem. Int. Ed.

    (1999)
  • G.J.D.A.A. Soler-Illia et al.

    Chemical strategies to design textured materials: from microporous and mesoporous oxides to nanonetworks and hierarchical structures

    Chem. Rev.

    (2002)
  • M. Vallet-Regi et al.

    A new property of MCM-41: drug delivery system

    Chem. Mater.

    (2001)
  • P. Yang et al.

    Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems

    Biomaterials

    (2007)
  • Cited by (46)

    View all citing articles on Scopus
    View full text